<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01490580</url>
  </required_header>
  <id_info>
    <org_study_id>PRETTINEO</org_study_id>
    <nct_id>NCT01490580</nct_id>
  </id_info>
  <brief_title>Premedication Trial for Tracheal Intubation of the NEOnate</brief_title>
  <acronym>PRETTINEO</acronym>
  <official_title>Double Blind Randomized Controlled Trial Comparing &quot;Atropine+Propofol&quot; Versus &quot;Atropine+Atracurium+Sufentanil&quot; as a Premedication Prior to Semi-urgent or Elective Endotracheal Intubation of Term and Preterm Newborns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal Creteil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ACTIV (Association Clinique et Thérapeutique du Val de Marne)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CRC (Centre de Recherche Clinique) du CHIC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Intercommunal Creteil</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter double blind randomized controlled trial comparing &quot;atropine+propofol&quot; vs
      &quot;atropine+atracurium+sufentanil&quot; as a premedication prior to endotracheal intubation of the
      neonate.

      Primary outcome: pulse oxymetry value &lt; 80% for more than 60 seconds. Secondary outcomes:
      number of attempts, duration of the procedure, changes in physiologic parameters, short- and
      long-term neurodevelopmental outcome.

      Hypothesis: &quot;atropine + propofol&quot; compared to &quot;atropine+atracurium+sufentanil&quot; will
      significantly reduce the frequency of severe hypoxemia.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Desaturation</measure>
    <time_frame>During intubation procedure, expected duration 1 to 15 minutes</time_frame>
    <description>Pulse oxymetry value measured by Masimo technology below 80% for 60 seconds or more.
Duration of intubation is defined by the time between first laryngoscope insertion and last laryngoscope removal after successful intubation. Successful intubation is defined by clear bilateral breath sounds, increasing heart rate and saturation (if previously low) and appropriate flow curves on the ventilator.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of intubation attempts</measure>
    <time_frame>During intubation procedure, expected duration 1 to 15 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of intubation procedure</measure>
    <time_frame>Expected duration 1 to 15 minutes</time_frame>
    <description>Duration of intubation is defined by the time between first laryngoscope insertion and last laryngoscope removal after successful intubation. Successful intubation is defined by clear bilateral breath sounds, increasing heart rate and saturation (if previously low) and appropriate flow curves on the ventilator.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>Heart rate recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short term neurological outcome</measure>
    <time_frame>Within 7 days after inclusion</time_frame>
    <description>Head ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term neurodevelopmental outcome</measure>
    <time_frame>At 2 years corrected age</time_frame>
    <description>Age and stages questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse oxymetry</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>Pulse oxymetry recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean blood pressure</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>Blood pressure recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcutaneous PCO2 (TcPCO2) measurement</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>TcPCO2 recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">173</enrollment>
  <condition>Premedication</condition>
  <condition>Endotracheal Intubation</condition>
  <arm_group>
    <arm_group_label>Atropine + Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Atropine + atracurium + sufentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>atropine+ propofol</intervention_name>
    <description>Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
    <arm_group_label>Atropine + Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>atropine + atracurium + sufentanil</intervention_name>
    <description>Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
    <arm_group_label>Atropine + atracurium + sufentanil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Corrected age &lt; 45 weeks of gestational age

          -  Currently hospitalized in a neonatal intensive care unit

          -  Requiring semi-urgent or elective intubation

          -  Equipped with a reliable and permeable IV line

          -  Parental consent

        Exclusion Criteria:

          -  Lack of parental consent

          -  Parental refusal

          -  Sedative or anesthetic treatment in the previous 24 hours

          -  Hemodynamic compromise defined as mean blood pressure&lt; corrected GA and/or refill time
             &gt; 3 seconds

          -  Upper airway malformation

          -  Life-threatening situation requiring immediate intubation

          -  Inclusion in another trial not permitting any other participation

          -  Impossibility to establish venous access

          -  Any contra-indication to any experimental drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Durrmeyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHI Creteil</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Médecine Néonatale et Réanimation Pédiatrique Polyvalente, CHU Amiens Nord</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Mère-Enfant</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Créteil</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital des Enfants</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Réanimation Pédiatrique et Néonatale de l'hôpital Clochevile, Centre Hospitalier Universitaire de Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2011</study_first_submitted>
  <study_first_submitted_qc>December 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2011</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Intercommunal Creteil</investigator_affiliation>
    <investigator_full_name>Xavier Durrmeyer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Newborn</keyword>
  <keyword>Anaesthesia</keyword>
  <keyword>opioids</keyword>
  <keyword>propofol</keyword>
  <keyword>neuromuscular blocker</keyword>
  <keyword>atropine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Atracurium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

